- Home
- STSS vs LIPO Comparison
STSS vs LIPO Comparison
Compare STSS & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STSS
- LIPO
- Stock Information
- Founded
- STSS 2017
- LIPO 2005
- Country
- STSS United States
- LIPO United States
- Employees
- STSS N/A
- LIPO N/A
- Industry
- STSS Medical/Dental Instruments
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- STSS Health Care
- LIPO Health Care
- Exchange
- STSS Nasdaq
- LIPO Nasdaq
- Market Cap
- STSS 3.3M
- LIPO 3.1M
- IPO Year
- STSS 2022
- LIPO 2022
- Fundamental
- Price
- STSS $0.37
- LIPO $2.19
- Analyst Decision
- STSS
- LIPO Strong Buy
- Analyst Count
- STSS 0
- LIPO 1
- Target Price
- STSS N/A
- LIPO $16.00
- AVG Volume (30 Days)
- STSS 41.3M
- LIPO 123.9K
- Earning Date
- STSS 03-31-2025
- LIPO 05-08-2025
- Dividend Yield
- STSS N/A
- LIPO N/A
- EPS Growth
- STSS N/A
- LIPO N/A
- EPS
- STSS N/A
- LIPO N/A
- Revenue
- STSS N/A
- LIPO $483,533.00
- Revenue This Year
- STSS N/A
- LIPO N/A
- Revenue Next Year
- STSS N/A
- LIPO N/A
- P/E Ratio
- STSS N/A
- LIPO N/A
- Revenue Growth
- STSS N/A
- LIPO 0.78
- 52 Week Low
- STSS $0.25
- LIPO $2.02
- 52 Week High
- STSS $18.15
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- STSS 42.15
- LIPO 37.65
- Support Level
- STSS $0.28
- LIPO $2.02
- Resistance Level
- STSS $0.70
- LIPO $2.34
- Average True Range (ATR)
- STSS 0.08
- LIPO 0.28
- MACD
- STSS 0.06
- LIPO -0.10
- Stochastic Oscillator
- STSS 26.32
- LIPO 11.64
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.